Table 8Summary of included studies. Comparison 7. Augmenting with self-help versus continuing with the antidepressant (+/− attention-placebo)

StudyPopulationInterventionComparisonDetails of inadequate response/treatment resistanceComments

Baert 2010_study 2

RCT

Belgium & Netherlands

N=44

Mean age (years): 42.3

Gender (% female): 64

Ethnicity (% BME): NR

Baseline severity: HAMD 23.19 (more severe)

Attentional bias training + any antidepressant

Intensity: 1x pre-training lab session, 10x training sessions at home, & 1 post-training lab session

Attention-placebo + any antidepressant

Intensity: 1x pre-training lab session, 10x training sessions at home, & 1 post-training lab session

Inadequate response: met inclusion criteria despite all participants having received therapy and/or medication at study entry

Treatment length (weeks): 1.4

Outcomes:

  • Depression symptomatology endpoint
  • Depression symptomatology change score

Dai 2019

RCT

China

N=40

Mean age (years): 38.7

Gender (% female): 45

Ethnicity (% BME): NR

Baseline severity: HAMD 23.01 (more severe)

Attentional bias training + any antidepressant

Intensity: 10 sessions (daily over 10 days)

Attention-placebo + any antidepressant

Intensity: 10 sessions (daily over 10 days)

Inadequate response (HAMD score≥20) despite at least 6 weeks of adequate antidepressant treatment

Treatment length (weeks): 1.4

Outcomes:

  • Depression symptomatology at:
    • Endpoint
    • 1-month follow-up
  • Depression symptomatology change score
  • Discontinuation due to any reason

Schlogelhofer 2014

RCT

Austria

N=90

Mean age (years): 47.8

Gender (% female): 67

Ethnicity (% BME): NR

Baseline severity: HAMD 12.6 (less severe)

Cognitive bibliotherapy + any antidepressant

Intensity: 1 monitoring session

Any antidepressantInadequate response (not achieving full remission, HAMD score 10-19) to at least 1 course of a recommended dose of an antidepressant medication for at least 4 weeks (the median treatment duration with antidepressant medication before screening was 6 months)

Treatment length (weeks): 6

Outcomes:

  • Depression symptomatology endpoint
  • Depression symptomatology change score
  • Discontinuation due to any reason

BME: black and minority ethnic; HAMD: Hamilton depression scale; NR: not reported; RCT: randomised controlled trial

From: Further-line treatment

Cover of Further-line treatment
Further-line treatment: Depression in adults: Evidence review D.
NICE Guideline, No. 222.
Copyright © NICE 2022.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.